{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:33:45Z","timestamp":1782902025911,"version":"3.54.5"},"reference-count":118,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Behav. Neurosci."],"DOI":"10.3389\/fnbeh.2017.00075","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T04:49:18Z","timestamp":1493786958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157\/BST1 Gene, a Risk Factor for Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Satoka","family":"Kasai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lopatina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiro","family":"Higashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1002\/mds.870080508","article-title":"Symptomatic effect of selegiline in de novo parkinsonian patients","volume":"8","author":"Allain","year":"1993","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.physbeh.2016.04.052","article-title":"Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse","volume":"163","author":"Amiri","year":"2016","journal-title":"Physiol. Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/ene.12724","article-title":"A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson\u2019s disease patients","volume":"22","author":"Barone","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000124701","article-title":"Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems","volume":"45","author":"Beaulieu","year":"1987","journal-title":"Neuroendocrinology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s0140-6736(77)91940-7","article-title":"Implications of combined treatment with \u201cMadopar\u201d and L-deprenil in Parkinson\u2019s disease. A long-term study","volume":"309","author":"Birkmayer","year":"1977","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/bf01249880","article-title":"L-Deprenyl plus L-phenylalanine in the treatment of depression","volume":"59","author":"Birkmayer","year":"1984","journal-title":"J. Neural Transm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1038\/srep19796","article-title":"Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice","volume":"6","author":"Bittolo","year":"2016","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-540-79850-7_1","article-title":"Neuroanatomy and pathology of sporadic Parkinson\u2019s disease","volume":"201","author":"Braak","year":"2009","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00019052-200108000-00006","article-title":"Depression in Parkinson\u2019s disease","volume":"14","author":"Brooks","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/nbdi.2001.0393","article-title":"The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome","volume":"8","author":"Callizot","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.parkreldis.2013.11.009","article-title":"BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson\u2019s disease in a Taiwanese population","volume":"20","author":"Chen","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s0022-510x(99)00198-7","article-title":"The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson\u2019s disease","volume":"172","author":"Choi","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson\u2019s disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/jnnp.34.5.502","article-title":"Psychiatric aspects in Parkinsonism treated with L-dopa","volume":"34","author":"Dam\u00e3sio","year":"1971","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/da.10057","article-title":"Depression and parkinson\u2019s disease: a new look at an old problem","volume":"16","author":"Edwards","year":"2002","journal-title":"Depress. Anxiety"},{"key":"B23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of L-DOPA treatment","volume":"35","author":"Eskow Jeunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000123182","article-title":"Amygdalectomy inhibits adrenocortical responses to somatosensory and olfactory stimulation","volume":"32","author":"Feldman","year":"1981","journal-title":"Neuroendocrinology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s002510050654","article-title":"The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene","volume":"49","author":"Ferrero","year":"1999","journal-title":"Immunogenetics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/s0028-3908(02)00216-2","article-title":"Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours","volume":"43","author":"Finberg","year":"2002","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s007020050209","article-title":"Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub\/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice","volume":"106","author":"Fredriksson","year":"1999","journal-title":"J. Neural Transm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1182\/blood-2004-06-2129","article-title":"CD157 is an important mediator of neutrophil adhesion and migration","volume":"104","author":"Funaro","year":"2004","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1111\/j.1742-4658.2005.04863.xot","article-title":"Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR)","volume":"272","author":"Guse","year":"2005","journal-title":"FEBS J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10571-009-9458-3","article-title":"Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo","volume":"30","author":"Gy\u00e1rf\u00e1s","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnsys.2016.00020","article-title":"Cortical-subcortical interactions in depression: from animal models to human psychopathology","volume":"10","author":"Heller","year":"2016","journal-title":"Front. Syst. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front. Neuroendocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12868-017-0350-7","article-title":"An immunohistochemical, enzymatic, and behavioral study of CD157\/BST-1 as a neuroregulator","volume":"18","author":"Higashida","year":"2017","journal-title":"BMC Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neuint.2012.01.030","article-title":"Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38","volume":"61","author":"Higashida","year":"2012","journal-title":"Neurochem. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0014-5793(94)01279-2","article-title":"ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1","volume":"356","author":"Hirata","year":"1994","journal-title":"FEBS Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/s0893-133x(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jad.2015.05.029","article-title":"Abnormal amygdala function in Parkinson\u2019s disease patients and its relationship to depression","volume":"183","author":"Huang","year":"2015","journal-title":"J. Affect. Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/s0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"377","author":"Nalls","year":"2011","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000058772","article-title":"BST-1\/CD157 regulates the humoral immune responses in vivo","volume":"75","author":"Ishihara","year":"2000","journal-title":"Chem. Immunol."},{"key":"B39","first-page":"1086","article-title":"CD157 (BST-1) workshop panel report","volume-title":"Leucocyte Typing VI","author":"Ishihara","year":"1997"},{"key":"B40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2014.01.064","article-title":"Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells","volume":"727","author":"Ishima","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.4049\/jimmunol.161.8.3974","article-title":"Deletion of bone marrow stromal cell antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses","volume":"161","author":"Itoh","year":"1998","journal-title":"J. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1006\/bbrc.1994.2325","article-title":"Molecular cloning of murine BST-1 having homology with CD38 and Aplysia ADP-ribosyl cyclase","volume":"203","author":"Itoh","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2202-15-79","article-title":"Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson\u2019s disease","volume":"15","author":"Kadoguchi","year":"2014","journal-title":"BMC Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1073\/pnas.91.12.5325","article-title":"BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth","volume":"91","author":"Kaisho","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awm239","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson\u2019s disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0014-2999(81)90269-7","article-title":"Effects of antidepressants in the rat forced swimming test","volume":"72","author":"Kitada","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00210-009-0405-0","article-title":"Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats","volume":"380","author":"Kitagawa","year":"2009","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B49","first-page":"431","article-title":"Neuroprotection of MAO-B inhibitor and dopamine agonist in parkinson disease","volume":"8","author":"Kong","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/mds.22221","article-title":"Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson\u2019s disease","volume":"23","author":"Kummer","year":"2008","journal-title":"Mov. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0702389","article-title":"Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo","volume":"126","author":"Lamensdorf","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1166\/msr.2012.1005","article-title":"The cyclic ADP-ribose\/NAADP\/CD38-signaling pathway: past and present","volume":"1","author":"Lee","year":"2012","journal-title":"Messenger"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/mds.22233","article-title":"Anxiety rating scales in Parkinson\u2019s disease: critique and recommendations","volume":"23","author":"Leentjens","year":"2008","journal-title":"Mov. Disord."},{"key":"B55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1468-1331.2008.02058.x","article-title":"Depressive symptoms in Parkinson\u2019s disease","volume":"15","author":"Lemke","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4088\/jcp.v57n1002","article-title":"Movement disorders associated with the serotonin selective reuptake inhibitors","volume":"57","author":"Leo","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0300-483x(01)00541-8","article-title":"Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum","volume":"170","author":"Leret","year":"2002","journal-title":"Toxicology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: the PDgene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e76651","DOI":"10.1371\/journal.pone.0076651","article-title":"Comparative efficacy and acceptability of antidepressants in Parkinson\u2019s disease: a network meta-analysis","volume":"8","author":"Liu","year":"","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/mds.25599","article-title":"Analysis of genome-wide association study-linked loci in parkinson\u2019s disease of mainland china","volume":"28","author":"Liu","year":"","journal-title":"Mov. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2350-12-104","article-title":"Genome-wide association study identifies candidate genes for Parkinson\u2019s disease in an Ashkenazi Jewish population","volume":"12","author":"Liu","year":"2011","journal-title":"BMC Med. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2741\/4213","article-title":"CD157 at the intersection between leukocyte trafficking and epithelial ovarian cancer invasion","volume":"19","author":"Lo Buono","year":"2014","journal-title":"Front. Biosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fnbeh.2014.00133","article-title":"Anxiety- and depression-like behavior in mice lacking the CD157\/BST1 gene, a risk factor for Parkinson\u2019s disease","volume":"8","author":"Lopatina","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0014-2999(97)00066-6","article-title":"The behavioural effects of pramipexole, a novel dopamine receptor agonist","volume":"324","author":"Maj","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2119\/2006-00094.Molmed","article-title":"CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity","volume":"12","author":"Malavasi","year":"2006","journal-title":"Mol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/0024-3205(80)90350-1","article-title":"L-Deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression","volume":"26","author":"Mann","year":"1980","journal-title":"Life Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp.36.6.925","article-title":"Does levodopa alter depression and psychopathology in Parkinsonism patients?","volume":"36","author":"Marsh","year":"1973","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/s0893-133x(99)00129-3","article-title":"Allostasis and allostatic load: implications for neuropsychopharmacology","volume":"22","author":"McEwen","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/mds.22586","article-title":"The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson\u2019s disease","volume":"24","author":"Menza","year":"2009","journal-title":"Mov. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/brainsci5010003","article-title":"Lipo-oxytocin-1, a novel oxytocin analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in CD157 knockout mice","volume":"5","author":"Mizuno","year":"2015","journal-title":"Brain Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1006\/bbrc.2000.4037","article-title":"Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes","volume":"279","author":"Mizuta","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/10409238.2013.789479","article-title":"NAD+ metabolism: a therapeutic target for age-related metabolic disease","volume":"48","author":"Mouchiroud","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0165-2478(96)02633-8","article-title":"Genomic structure of human BST-1","volume":"54","author":"Muraoka","year":"1996","journal-title":"Immunol. Lett."},{"key":"B75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s0006-8993(02)02238-2","article-title":"Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson\u2019s disease","volume":"930","author":"Nakazato","year":"2002","journal-title":"Brain Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1586\/ern.13.60","article-title":"Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms","volume":"13","author":"Naoi","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson\u2019s disease: the French cross-sectionnal DoPaMiP study","volume":"25","author":"N\u00e8gre-Pag\u00e8s","year":"2010","journal-title":"Mov. Disord."},{"key":"B79","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1006\/bbrc.1996.1741","article-title":"Human BST-1 expressed on myeloid cells functions as a receptor molecule","volume":"228","author":"Okuyama","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/jnci\/djq256","article-title":"Functional role and prognostic significance of CD157 in ovarian carcinoma","volume":"102","author":"Ortolan","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"B81","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00415-009-5353-6","article-title":"Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson\u2019s disease and major depression","volume":"257","author":"P\u00e5lhagen","year":"2010","journal-title":"J. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/fbp.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1074\/jbc.m408085200","article-title":"Concentrative uptake of cyclic ADP-ribose generated by BST-1+ stroma stimulates proliferation of human hematopoietic progenitors","volume":"280","author":"Podest\u00e0","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B84","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/cyto.b.21092","article-title":"CD38 and CD157: a long journey from activation markers to multifunctional molecules","author":"Quarona","year":"2013","journal-title":"Cytometry B Clin. Cytom."},{"key":"B86","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jep.2012.07.032","article-title":"SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson\u2019s disease","volume":"143","author":"Rajendra Kopalli","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0149-7634(97)00001-8","article-title":"Stress and emotionality: a multidimensional and genetic approach","volume":"22","author":"Ramos","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0166-4328(02)00203-6","article-title":"In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/NA antidepressant treatments may produce greater effects than selective drugs","volume":"136","author":"R\u00e9n\u00e9ric","year":"","journal-title":"Behav. Brain Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0924-977x(02)00007-x","article-title":"In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed","volume":"12","author":"R\u00e9n\u00e9ric","year":"","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/s1734-1140(12)70936-2","article-title":"Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test","volume":"64","author":"Rog\u00f3z","year":"2012","journal-title":"Pharmacol. Reports"},{"key":"B91","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/hmg\/ddq497","article-title":"Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson\u2019s disease in the European population","volume":"20","author":"Saad","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B92","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrn1555","article-title":"Stress, cognitive impairment and cell adhesion molecules","volume":"5","author":"Sandi","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolsky","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"CD003465","DOI":"10.1002\/14651858.CD003465","article-title":"Therapies for depression in Parkinson\u2019s disease","volume":"2","author":"Shabnam","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1212\/WNL.0b013e318264e353","article-title":"Large-scale replication and heterogeneity in Parkinson disease genetic loci","volume":"79","author":"Sharma","year":"2012","journal-title":"Neurology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0152581","DOI":"10.1371\/journal.pone.0152581","article-title":"Genetic polymorphisms affect mouse and human trace amine-associated receptor 1 function","volume":"11","author":"Shi","year":"2016","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1172\/jci3162","article-title":"Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells","volume":"102","author":"Shimaoka","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.euroneuro.2005.02.003","article-title":"Antidepressant-like effects of selegiline in the forced swim test","volume":"15","author":"Shimazu","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ejhg.2010.254","article-title":"Genome-wide association study confirms extant PD risk loci among the Dutch","volume":"19","author":"Sim\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00213-004-1809-7","article-title":"The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors","volume":"175","author":"Siuciak","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e13452","DOI":"10.1371\/journal.pone.0013452","article-title":"The dopamine metabolite 3-methoxytyramine is a neuromodulator","volume":"5","author":"Sotnikova","year":"2010","journal-title":"PLoS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mds.21866","article-title":"A validation study of depressive syndromes in Parkinson\u2019s disease","volume":"23","author":"Starkstein","year":"2008","journal-title":"Mov. Disord."},{"key":"B105","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/jnnp.53.10.869","article-title":"Specificity of affective and autonomic symptoms of depression in Parkinson\u2019s disease","volume":"53","author":"Starkstein","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B106","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2007.09.008","article-title":"Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/WNL.0b013e3181eccfcd","article-title":"Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus","volume":"75","author":"Tan","year":"2010","journal-title":"Neurology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"B103","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/ddq469","article-title":"Dissection of the genetics of Parkinson\u2019s disease identifies an additional association 5\u2032 of SNCA and multiple associated haplotypes at 17q21","volume":"20","author":"Spencer","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","article-title":"Depressive symptoms in Parkinson\u2019s disease are related to decreased hippocampus and amygdala volume","volume":"30","author":"van Mierlo","year":"2015","journal-title":"Mov. Disord."},{"key":"B110","first-page":"289","article-title":"Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, \u201cE-250\u201d)","volume":"23","author":"Varga","year":"1967","journal-title":"Acta Med. Acad. Sci. Hung."},{"key":"B111","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/jnnp-2015-310383","article-title":"A smaller amygdala is associated with anxiety in Parkinson\u2019s disease: a combined FreeSurfer-VBM study","volume":"87","author":"Vriend","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B112","doi-asserted-by":"publisher","first-page":"CD006528","DOI":"10.1002\/14651858.CD006528.pub2","article-title":"Mirtazapine versus other antidepressive agents for depression","volume":"12","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/PL00022917","article-title":"Depression in Parkinson\u2019s disease: its prevalence, diagnosis, and neurochemical background","volume":"248","author":"Yamamoto","year":"2001","journal-title":"J. Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/brainsci5020188","article-title":"Association study between the CD157\/BST1 gene and autism spectrum disorders in a Japanese population","volume":"5","author":"Yokoyama","year":"2015","journal-title":"Brain Sci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5607\/en.2013.22.1.1","article-title":"Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and M30 derived from rasagiline","volume":"22","author":"Youdim","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s1353-8020(01)00011-6","article-title":"Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson\u2019s disease","volume":"8","author":"Youdim","year":"2002","journal-title":"Park. Relat. Disord."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/j.1471-4159.2008.05330.x","article-title":"Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration","volume":"105","author":"Zhu","year":"2008","journal-title":"J. Neurochem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/WCO.0b013e3283484b87","article-title":"Genetics of Parkinson\u2019s disease and essential tremor","volume":"24","author":"Zimprich","year":"2011","journal-title":"Curr. Opin. Neurol."}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnbeh.2017.00075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:25:13Z","timestamp":1692789913000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnbeh.2017.00075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":118,"alternative-id":["10.3389\/fnbeh.2017.00075"],"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2017.00075","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"article-number":"75"}}